Palmoplantar pustulosis - Pustulosis Ea Palmoplantarhttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Pustulosis Ea Palmoplantar (Palmoplantar pustulosis) ke lefu le sa foleng la pustular dermatosis (ke hore, pustulosis kapa pustular psoriasis) sebakeng sa liatla le soles feela, e khetholloang ka histologically ka intraepidermal pustules e tletseng li‑neutrophils. Tšebeliso ea systemic retinoids feela ’me hammoho le photochemotherapy ho ntlafatsa matšoao a pustulosis ea palmoplantar (palmoplantar pustulosis).

○ Kalafo
Oral acitretin e sebetsa hantle bakeng sa mofuta ona oa psoriasis.
#Acitretin
☆ AI Dermatology — Free Service
Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
  • Tabeng ena, pompholyx le eona e ka belaelloa.
  • Ha li-pustule (pustules) e se ho teng, eczema ea letsoho e ka boela ea nkoa e le tlhahlobo e fapaneng.
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar psoriasis ke mofuta oa psoriasis o amang haholo letlalo liatleng tsa hao le maotong. E bonahala e le letlalo le teteaneng le omme (hyperkeratotic), le qhibiliha (pustular), kapa motsoako oa mefuta ka bobeli (mixed).
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).